The GSDME-deficient mice and human TECs were employed to prove that caspase-3/GSDME-triggered pyroptosis and inflammation contribute to acute kidney injury, and treatments targeting GSDME could be a new insight into DKD [146]. This evidence concerns the gene CASP3 and diabetic kidney disease.